An AllTrials project

NCT04709835: A reported trial by Hoffmann-La Roche

This trial has reported on time, in line with the regulations.

Full data

Full entry on NCT04709835
Title A Phase II Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Antiviral Activity, Safety, Pharmacokinetics, and Efficacy of RO7496998 (AT-527) in Non-Hospitalized Adult Patients With Mild or Moderate COVID-19
Results Status Reported
ACT or pACT? This is what FDAAA officially calls an "Applicable Clinical Trial"
Start date Feb. 3, 2021
Completion date Sept. 17, 2021
Required reporting date Sept. 17, 2022, midnight
Actual reporting date Sept. 15, 2022
Date last checked at April 10, 2023
Days late None